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Evidence for Decreasing Occurrence of Sudden Cardiac Death Associated With the Marathon
To the Editor: The risk for sudden death caused by cardiovascular
disease associated with the marathon has previously been reported
as 1 in 50,000 finishers (1). In the last decade, road racing
participation has increased more than 50% worldwide (2), and
reports of fatal cardiac arrest during the marathon (and other road
racing) continue to draw media attention and raise questions
regarding the safety of this athletic activity. Therefore, we believe
that it is timely to reassess the database of the Twin Cities and
Marine Corps marathons through 2004 to determine whether the
risk of sudden death associated with marathon racing has changed
in the last decade, and specifically to establish whether the use of
external defibrillators have had a positive impact.
The case records and registries of the 42-km Marine Corps
Marathon (Washington, DC, 1976 to 2004) and the Twin Cities
Marathon (Minneapolis-St. Paul, Minnesota, 1982 to 2004)
spanning 29 years and a combined 52 races were reviewed. These
public urban marathons are held each fall with similar weather
conditions, attracting largely amateur racers who are not required
to submit either entry qualifying times or evidence of prepartici-
pation screening medical evaluations. Race records were analyzed
to calculate the event rates for sudden cardiac death and non-fatal
cardiac arrest and to compare the outcomes during the most recent
10-year period (1995 to 2004) with the original cohort from 1976
to 1994 (1). For those athletes who incurred cardiac events, a
retrospective analysis of their medical and athletic histories was
performed using available records and telephone interviews.
From 1976 to 2004, 441,924 runners successfully completed the
marathons; the 1976 to 1994 and 1995 to 2004 subsets have
virtually identical numbers of finishers, which permits comparisons
(Table 1). Although marathon finishers from 1976 to 2004 were
predominantly men, the proportion of women has increased from
18% during 1982 to 1994 to 37% for 1995 to 2004 (Table 1).
A total of five sudden cardiac deaths and four successfully
resuscitated cardiac arrests (three with documented ventricular
fibrillation and one initially with asystole), involving eight men and
one woman (ages 19 to 58 years), occurred during or shortly after
completing a marathon race (Table 2). Four of the five deaths
occurred before 1995, and only one (in the year 2000) was during
the most recent 10 years of this study.
The combined prevalence of sudden death and non-fatal cardiac
arrest (i.e., overall event rate) decreased slightly from 1 in 44,000
race finishers for the 1976 to 1994 time period to 1 in 55,000 for
1995 to 2004, unadjusted for age and gender. However, the
specific sudden cardiac death rates differed substantially for runners
before 1995 (1 per 55,000 finishers) compared with 1995 to 2004
(1 per 220,000 finishers) (Table 1).
The four cardiac arrest survivors had external defibrillation
performed promptly within 5 min, including three in whom sinus
rhythm was restored on site. Although cardiopulmonary resusci-
tation was attempted in all fatal and non-fatal cases, the precise
timing of resuscitation relative to collapse was not known for the
deaths that occurred in 1986, 1990, and 1993.
Seven of the nine runners with cardiac events, ages 32 to 58
years (all male), had underlying atherosclerotic coronary artery
disease (50% luminal narrowing) usually involving two or three
main extramural arteries (Table 2). Of these, only case #9 had
previously recognized disease, with coronary artery bypass grafting
nine years before the fatal cardiac arrest. The other two cardiac
events occurred in participants younger than 30 years of age
without atherosclerotic coronary artery disease. A 19-year-old
woman with anomalous origin of the left main coronary artery
from the right (anterior) sinus of Valsalva died, and a 28-year-old
man with cardiac arrest probably precipitated by a mitochondrial
myopathy survived (3). Six of the nine runners with cardiac events
had previously completed at least one other marathon.
The present analysis shows a sudden cardiac death rate of 1 in
220,000 marathon finishers during the last decade. This fatal event
prevalence is less than the 1 death per 100,000 finishers reported in
the combined New York City and London marathon races
through the mid-1990s (4), is eight-fold lower than the estimated
1 in 15,000 to 18,000 for men during jogging and other vigorous
exercise (5,6), and is four-fold less than our previously reported
marathon sudden death rate before 1995 (1). Furthermore, the
proportion of our runners with cardiac arrest who survived (four of
nine, 45%; and three of four, 75% in the last decade) is much
higher than the generally expected 5% survival with out-of-
hospital cardiac arrests in urban communities of North America
(7).
This decrease in mortality observed among race participants
experiencing cardiac arrest since 1995 is largely attributable to the
expanded access to external defibrillators now available on many
road racing courses, including the marathon. Indeed, four runners
survived their cardiac arrest primarily because of rapid defibrilla-
tion available within five minutes after collapse and rapid transfer
to advanced life-support systems. Nevertheless, our survival data
are not adjusted for demographic or other variables, and are not
intended to represent precise estimates of changing risk.
The vast majority of medical encounters related to the
marathon are relatively minor and self-limiting (8). Although



















1976–1994 221,318 11,648 153,855 (82%)* 34,123 (18%)* 1 0.0005 0.5 4 0.0018 1.8
1995–2004 220,606 22,060 141,800 (63%) 78,806 (37%) 3 0.0014 1.4 1 0.0005 0.45
Total 441,924 15,239 295,655 (72%)* 112,929 (28%)* 4 0.0009 0.9 5 0.0011 1.1
*Gender breakdown for 1976–1981 not available.
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cardiac arrest is a rare occurrence, the clear implication of our
data is that contemporary marathon race medical preparation
with advanced life support (including rapid access to defibril-
lation) is life-saving. Successful defibrillations in both marathon
events used manually operated defibrillators and rapid response
teams that often included physicians, paramedics, and emer-
gency medical technicians. Defibrillators and operators were
placed in fixed medical aid stations at two- to three-mile
intervals along the race route, at the finish line, and in mobile
ambulances. Both marathons also currently deploy mobile
first-response teams equipped with automatic external defibril-
lators moving along the race course with the runners on bicycles
and in golf carts to facilitate access to defibrillation. In addition,
race personnel are equipped with cell phones and short-wave
radios for alerting the medical teams should a runner collapse.
Indeed, it is our experience that the major determinant of
survival from cardiac arrest during the marathon is the proxim-
ity of a defibrillator to a collapsed runner.
In conclusion, marathon road racing, although increasing in
popularity and participation, is associated with a low (and decreas-
ing) risk for sudden cardiac death largely because of the availability
of advanced life support and timely defibrillation. That risk over
the last 10 years is only 1 in 220,000 race participants. These
observations offer an important measure of reassurance to potential
marathon participants and underscore the power of rapid defibril-
lation after cardiac arrest for enhancing the safety of sports
competition.
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Letters to the Editor
Cardiac Transplant Following
Failed Fontan or Glenn Procedures
It is with great interest that we read the study by Jayakumar et
al. (1) on the outcome following cardiac transplantation after a
failed Fontan or Glenn procedure. Because adults and children
were included in the study population, it is difficult to draw
meaningful comparisons to posttransplant survival data. Nev-
ertheless, in the more recent era of overall pediatric and adult
cardiac transplantation (1994 to 1998). International Society for
Heart and Lung Transplantation (ISHLT) Kaplan-Meier sur-
vival rates are reported at 80% and 82% at one year and 74% and
70% at five years’ posttransplant, respectively (2,3). In this
context, patient survival with cardiac transplantation after a
failed Fontan procedure, reported by Jayakumar et al. as 63% at
one year, and 57% at five years, is of concern (1). The
investigators have reported five-year combined survival rates in
both groups (post-Fontan and post-Glenn) in a later era
(1996–2001) as 77%, but it would be useful to report the
posttransplant survival in the failed Fontan patients separately
in this later period as these patients seem to have a worse
outcome than those transplanted after a Glenn procedure. The
majority of deaths occurred within seven days after transplan-
tation, and they were due to hemorrhage, multiorgan failure,
sepsis, and right ventricular failure. The increased mortality
Table 2. Clinical Data for Cardiac Events Occurring in Nine Marathon Runners
Cardiac Event Age/Gender Year Marathon Cardiovascular Disease
No. Prior
Marathons Circumstances of Collapse
Nonfatal cardiac arrest
1 46 M 1994 MC CAD — Mile #8
2 54 M 1996 MC CAD 1 Mile #21 (aid station)*
3 28 M 2000 TC Mitochondrial myopathy 1 At finish line†
4 52 M 2003 TC CAD 3 100 meters before finish
Sudden cardiac death
5 32 M 1986 MC CAD 3 Mile #15
6 40 M 1989 TC CAD 0 15 min after completing race†
7 19 F 1990 MC Anomalous LMCA 0 Mile #24
8 58 M 1993 MC CAD 3 Mile #23
9 54 M 2000 MC CAD‡ 1 Mile #2
*Evaluated for excessive fatigue; documented to have acute myocardial infarction. †Completed race in 4.5 h. ‡Previous coronary artery bypass grafting (three arteries).
CAD  atherosclerotic coronary artery disease; F  female; M  male; LMCA  left main coronary artery; MC Marine Corps Marathon; TC  Twin Cities Marathon.
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